Fusion Antibodies
Richard Buick is an experienced professional in the field of antibody engineering, currently serving as the Chief Scientific Officer, Chief Technical Officer, and Technical Director at Fusion Antibodies plc since April 2002. As a member of the executive management team, Richard oversees all contract research projects and in-house initiatives focused on proteins and antibody engineering. Prior to this role, Richard worked as a Senior Research Scientist, where contributions included the introduction of antibody engineering services and the development of techniques such as chimerization and CDR-grafting. Earlier experience includes a position as a Research Scientist at Randox, where Richard produced several recombinant proteins in E. coli. Richard holds a PhD in Antibody Engineering and a BSc (Honours) in Genetics from Queen's University Belfast.
This person is not in any teams
Fusion Antibodies
Since 2001, Fusion Antibodies has been dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry. We offer a complete range of antibody-related services in Discovery, Engineering and Supply and have guided hundreds of projects through critical preclinical stages. Fifteen of our client’s projects have advanced to clinical stages, some as far as Phase II. We deliver a superior service for the development of antibodies by beginning each project with the end in mind. Our scientists are experts in early stage discovery of biologics. We offer this personalised service because we know that investment at the early stages saves not only millions of dollars but also months, even years of time, on projects that go awry at later stages of development. Through our vast experience we have developed a number of our own proprietary platforms for Antibody Humanization (CRX™), Affinity Maturation (RAMP™) and Developability optimisation (ADD™). Fusion Antibodies is a publicly held company, trading on the London Stock Exchange (LSE FAB.L) with headquarters in Belfast, Northern Ireland.